You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,476,689


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,476,689
Title:Therapeutic compositions for intranasal administration which include KETOROLAC
Abstract:An analgesic/anti-inflammatory pharmaceutical dosage form which comprises an effective amount of an active ingredient selected from the group consisting of racemic 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid, optically active forms thereof and pharmaceutically acceptable salts thereof, in combination with a pharmaceutically acceptable excipient or diluent, said dosage form being an intranasally administrable dosage form.
Inventor(s): Santus; Giancarlo (Milan, IT), Bottoni; Giuseppe (Bergamo, IT), Bilato; Ettore (Padova, IT)
Assignee: Recordati Ireland Limited (IE)
Application Number:10/792,457
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Compound; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of U.S. patents, using the example of U.S. Patent 7,476,689 to illustrate key concepts and trends in the patent landscape.

What is a U.S. Patent?

A U.S. patent is a grant of rights from the U.S. government to an inventor for a new and useful invention. The U.S. Patent and Trademark Office (USPTO) is responsible for granting these patents and registering trademarks[2].

Patent Eligible Subject Matter

To be patentable, an invention must fall under one of the four categories defined by Section 101 of the Patent Act: any new and useful process, machine, manufacture, or composition of matter. However, there are judicially developed exceptions that exclude certain types of inventions, such as abstract ideas, natural phenomena, and laws of nature[5].

The Patent Application Process

The journey to obtaining a U.S. patent involves several steps, including filing an application, undergoing examination, and potentially using continuation procedures. The USPTO examines applications to determine if the invention is novel, non-obvious, and useful. The allowance rate for patent applications has decreased over time, particularly in fields like drugs and medical instruments, and computers and communications[1].

Patent Claims

Patent claims define the scope of the invention and are critical in determining what is protected by the patent. Two simple metrics for measuring patent scope are independent claim length and independent claim count. Narrower claims are associated with a higher probability of grant and a shorter examination process[3].

Example: U.S. Patent 7,476,689

To illustrate these concepts, let's consider U.S. Patent 7,476,689, though the specific details of this patent are not provided here. Here is how the general principles apply:

Patent Claims and Scope

  • The claims section of a patent like 7,476,689 would detail what the inventor considers to be the novel and non-obvious aspects of the invention.
  • Independent claims are typically broader and define the overall scope of the invention, while dependent claims are narrower and build upon the independent claims.
  • The length and count of independent claims can influence the patent's scope and the likelihood of it being granted. For instance, narrower claims are often favored as they are more likely to be granted and result in a shorter examination process[3].

Patent Eligible Subject Matter

  • The invention described in 7,476,689 must fall within the categories of patentable subject matter as defined by Section 101 of the Patent Act.
  • It must not be an abstract idea, natural phenomenon, or law of nature, which are excluded from patentability under the judicially developed exceptions[5].

Examination Process

  • The patent application for 7,476,689 would have undergone a rigorous examination process at the USPTO.
  • The examiner would have evaluated the application to ensure it meets the criteria of novelty, non-obviousness, and utility.
  • The applicant may have used continuation procedures, such as Requests for Continued Examination (RCEs), to address any issues raised during the examination process[1].

Trends in Patent Landscape

Technology Areas

  • Patents are classified into various technology areas, such as electrical engineering, mechanical engineering, and computer technology.
  • The number of patents in certain areas, like electrical engineering and computer technology, has significantly increased over the years, reflecting the growing importance of information and communication technologies (ICT)[4].

Global and Domestic Trends

  • In 2018, the USPTO awarded 309,000 utility patents, with a nearly equal split between foreign and domestic inventors.
  • Businesses received the majority of these patents, with individuals, the academic sector, and the government sector receiving smaller shares[4].

Impact of Judicial Decisions

  • Judicial decisions, such as the Alice/Mayo framework, have significantly impacted the patent landscape, particularly for emerging technologies like AI.
  • These decisions have narrowed the scope of patent-eligible subject matter, affecting the allowance rates for certain types of patent applications[5].

Continuation Procedures

Continuation procedures are often used to address issues raised during the patent examination process. These procedures can be non-serialized (e.g., Requests for Continued Examination) or serialized, and they allow applicants to refine their applications or pursue related inventions[1].

Key Metrics for Patent Allowance Rates

  • The first-action allowance rate, progenitor allowance rate, and family allowance rate are key metrics in understanding the probability of a patent being granted.
  • These rates have decreased over time, especially in certain technology fields, indicating a more stringent examination process[1].

Conclusion

Understanding the scope and claims of a U.S. patent, as well as the broader patent landscape, is essential for navigating the complex world of intellectual property. Here are some key takeaways:

  • Patent Claims: Narrower claims are associated with a higher probability of grant and a shorter examination process.
  • Patent Eligible Subject Matter: Inventions must fall within specific categories defined by Section 101 of the Patent Act.
  • Examination Process: The USPTO examines applications rigorously, and continuation procedures can be used to address issues.
  • Trends in Patent Landscape: Certain technology areas are seeing significant growth, and judicial decisions are impacting patent eligibility.

Key Takeaways

  • Patent Scope: Defined by independent claim length and count.
  • Patent Eligibility: Must meet Section 101 criteria and avoid judicially developed exceptions.
  • Examination Process: Involves rigorous evaluation and potential use of continuation procedures.
  • Trends: Reflect growing importance of ICT and impact of judicial decisions.

FAQs

Q: What is the typical allowance rate for U.S. patent applications? A: The overall allowance rate for U.S. patent applications is approximately 55.8% without using continuation procedures[1].

Q: How do continuation procedures affect the patent application process? A: Continuation procedures allow applicants to refine their applications or pursue related inventions, addressing issues raised during examination[1].

Q: What are the key metrics for measuring patent scope? A: Independent claim length and independent claim count are simple yet effective metrics for measuring patent scope[3].

Q: How have judicial decisions impacted patent eligibility? A: Judicial decisions, such as the Alice/Mayo framework, have narrowed the scope of patent-eligible subject matter, particularly affecting emerging technologies like AI[5].

Q: What are the most common technology areas for U.S. patents? A: Electrical engineering and mechanical engineering patents make up a significant portion of USPTO-granted patents, with a notable increase in electrical engineering patents due to ICT[4].

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203.
  2. U.S. Patent and Trademark Office (USPTO). Retrieved from https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. Patent Claims and Patent Scope. (2016). SSRN. Retrieved from https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. National Science Foundation. (2020). Invention: U.S. and Comparative Global Trends. Retrieved from https://ncses.nsf.gov/pubs/nsb20204/invention-u-s-and-comparative-global-trends
  5. Congressional Research Service. (2024). Patent-Eligible Subject Matter Reform: An Overview. Retrieved from https://crsreports.congress.gov/product/pdf/IF/IF12563

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,476,689

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 7,476,689

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
ItalyMI91A2024Jul 22, 1991

International Family Members for US Patent 7,476,689

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 130758 ⤷  Subscribe
Germany 69206345 ⤷  Subscribe
Denmark 0524587 ⤷  Subscribe
European Patent Office 0524587 ⤷  Subscribe
Spain 2082288 ⤷  Subscribe
Greece 3019012 ⤷  Subscribe
Italy 1250691 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.